Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
St. Paul, MN, April 08, 2026 (GLOBE NEWSWIRE) -- As temperatures climb and heat stress risks return to jobsites across the country, Ergodyne is rolling out new cooling gear and worksite shelters...
-
23andMe Research Institute Study, Published in Nature, Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects
-
Langenfeld, Germany, April 08, 2026 (GLOBE NEWSWIRE) -- Booking Health, a global medical travel provider, announced today the release of its 2026 report on advanced head and neck cancer treatment...
-
Vail, Colorado, April 08, 2026 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI), in collaboration with New York-based Hospital for Special Surgery (HSS) and with support from Vail...
-
Franklin, TN, April 08, 2026 (GLOBE NEWSWIRE) -- ROOT Brands®, a science-driven wellness company led by Chief Science Officer Dr. Christina Rahm and Chief Executive Officer Clayton Thomas, today...
-
Tekton Research announces the opening of its San Antonio research hub, a physician-led clinical research center.
-
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine...
-
ASHEVILLE, N.C., April 08, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health, a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services,...
-
NEW YORK, USA, April 08, 2026 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Functional Service Providers Market By Type (Clinical Monitoring, Medical Writing,...
-
Ritedose partners with Tenpoint Therapeutics to manufacture YUVEZZI™, the first FDA-approved dual-action eye drop for presbyopia.